Adrenal News

The prevalence of primary aldosteronism among adults with type 2 diabetes is relatively low, but those with primary aldosteronism have higher systolic blood pressure and lower potassium levels than those without adrenal dysfunction, according to published findings.

Patients with adrenal insufficiency may accrue substantial health care costs and have more hospital stays and outpatient visits compared with healthy controls, according to findings published in the Journal of the Endocrine Society.

Patients with hypothalamic-pituitary-adrenal axis dysregulations report health-related quality of life that is far lower than that of the general population, according to findings of a prospective study.

ORLANDO, Fla. — Highly potent selective androgen receptor degraders, or SARDs, may provide advanced treatment options for men with castration-resistant prostate cancer, according to study findings presented here.

ORLANDO, Fla. — Older age at adrenocortical carcinoma symptom onset and higher stage disease are independently associated with overall survival in adolescents with adrenocortical carcinoma, according to research presented here.

ORLANDO, Fla. — It was Christmas Day in 1914 when the Mayo Clinic chemist Edward C. Kendall, PhD, first succeeded in isolating pure crystalline thyroxin using 6,500 pounds of hog thyroid glands, a success that would set him on the course for making one of the greatest discoveries in medicine in the last century.

Nearly half of adults with Cushing’s disease that persists or recurs after surgical treatment require second and sometimes third therapeutic interventions, including pituitary surgical reintervention, radiotherapy, pharmacotherapy or bilateral adrenalectomy, study data from Mexico show.

Postmenopausal women may have higher serum sex hormone-binding globulin concentrations if they consume low glucose load/glucose index diets with low sugar and high fiber content, according to findings published in the Journal of Diabetes.

In healthy, normotensive men, treatment with moxonidine therapy for 6 weeks resulted in a decrease in blood pressure without altering the aldosterone-to-renin ratio, minimizing the risk for false-positive results in screening for primary aldosteronism, according to findings from researchers in Australia.

Early and midterm nonremission after transsphenoidal surgery in people with Cushing’s disease may be predicted by normalized early postoperative values for adrenocorticotropic hormone and cortisol, study data show.